Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A new study published Thursday warns that tiger mosquitoes are increasingly spreading to Europe because of climate change, ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...

Most stories of chikungunya begin with something oddly harmless — a slight twitch in the toes or fingers. That’s when the ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.